Enable JavaScript to visit this website.
Skip directly to content

Our Voice

Tuesday, March 15, 2022
Over the past two years, Canadians have seen first-hand the contributions of the research-based pharmaceutical industry at work.
Wednesday, March 9, 2022
Pfizer Canada is proud to announce the recipients of the 2021 Canadian transthyretin amyloid cardiomyopathy (ATTR-CM) Medical Research and
Tuesday, March 8, 2022
by Cole Pinnow, President, Pfizer Canada
Today, I am proud to share that Pfizer Canada has been recognized as one of Canada’s Best Diversity